Roivant is rapidly developing innovative medicines through a novel form of industrial organization in R&D.
Leadership
Matthew Gline
Fund
SVF1
Status
NASDAQ: ROIV
Sector
Health Tech
Region
Americas
Roivant is rapidly developing innovative medicines through a novel form of industrial organization in R&D.